NAS
WST icon

Nykredit A/S’s West Pharmaceutical WST Stock Holding History

Nykredit A/S’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.78M Buy
+24,456
New +$7.48M 0.03% 373

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Nykredit A/S's WST Position: Q2 2026 in Review

Nykredit A/S opened a new position in West Pharmaceutical (WST) in Q2 2026: 24,456 shares worth $8.78M. The stake represents 0.03% of the portfolio and ranks #373 among its holdings.

834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Nykredit A/S held 24,456 shares of West Pharmaceutical worth $8.78M as of Q2 2026.
  • West Pharmaceutical was a new Nykredit A/S position in Q2 2026.
  • West Pharmaceutical made up 0.03% of Nykredit A/S's portfolio in Q2 2026, its #373 holding.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.